Epigenetic BET inhibitor apabetalone counters inflammatory and fibrotic processes in activated cardiac fibroblasts providing insight into reduced hospitalizations for heart failure in BETonMACE trial
1 September 2024 (10:00 - 10:10)
Organised by: 
About the speaker
Calgary (Canada)
5 More presentations in this session
Assistant Professor A. Mengozzi (Pisa, IT)
Doctor S. Costantino (Zurich, CH)
Doctor Z. Qiu (Shanghai, CN)
Access the full session
The Event
ESC Congress 2024
1 September 2024
10:00 CET
You may be interested in
Congress Session
